Form 4 for CSL CARLISLE COMPANIES INC
Accepted 2023-02-01 00:00:00 ET · period of report 2023-01-31 · accession 0000790051-23-000019 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-01 | 2023-01-31 | CSL | Zdimal Kevin P | VP, CFO | A - Grant | $0.00 | +1,740 | 37.6K | +5% | $0 |
| D | 2023-02-01 | 2023-01-31 | CSL | Zdimal Kevin P | VP, CFO | A - Grant | $0.00 | +5,845 | 5,845 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-31 | A | A | 1,740 | $0.00 | 37,554 | D | — | — | (F1) Represents a grant of 1,740 restricted shares from the issuer for services as an executive officer of the issuer. (F2) Includes 46 shares acquired in the issuer's defined contribution plan during the prior year. |
| 2 | Derivative | Employee Stock Option (Right to Buy) | 2023-01-31 | A | A | 5,845 | $0.00 | 5,845 | D | $250.86 · — to 2033-01-30 | 5,845 Common Stock | (F3) The option vests in three equal annual installments beginning on January 31, 2024. |